Abbott Completes $21B Exact Sciences Deal To Expand Cancer Diagnostics

 
• By Shubham Singh
  
Abbott
Abbott said the acquisition positions the company to advance diagnostics that are more preventative, predictive and personalized while expanding its presence in cancer screening and precision oncology diagnostics.

More from Deals

More from Business